An AI ultrasound analysis tool for prenatal care teams that automates fetal measurements, supports computer-assisted diagnosis, and enables teleguidance.

DeepEcho is an AI-powered ultrasound analysis software for prenatal care teams, designed to assist radiologists and minimally trained clinicians with ultrasound video diagnosis.
Key capabilities include:
Platform availability is not publicly specified; the company describes the solution as mobile and hardware agnostic for broader deployment across different ultrasound setups.
Target users include hospitals, radiologists, gynecologists, midwives, and prenatal care providers seeking automated fetal biometry and decision support in antenatal ultrasound.
Notable context: the company operates from Rabat, Morocco (and is Delaware-incorporated) and positions the product for deployment in underserved settings. It also references peer-reviewed research on automation of fetal biometry and amniotic fluid assessment (including a Nature Communications publication) and has received recognition such as TIME & Statista Top HealthTech Companies of 2025 and GITEX Africa 2024 awards.
Contact: contact@deepecho.io
DD Dave found 3 key people at DeepEcho, including 2 Founder, and 1 C-Suite spread across 3 countries. See how we get product data
Sign in to see all 3 team members
Get full profiles with titles, social links, and more
No reviews yet. Be the first to review this product.
DD Dave found that DeepEcho has raised $600,000 across 5 rounds, backed by 5 investors. Their latest round was a Grant in Feb 2026. See how we get product data